Arbutus Biopharma Stock Target Price and Analyst Consensus
| ABUS Stock | USD 3.20 0.02 0.62% |
The current analyst and expert consensus on Arbutus Biopharma is Strong Buy, with 2 strong buy opinions. The current projected Arbutus Biopharma target price consensus is 5.08 with 5 analyst opinions. Check out Macroaxis Advice on Arbutus Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Arbutus Biopharma Corp analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Arbutus Biopharma executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Arbutus Biopharma. We strongly encourage you to use your own analysis of Arbutus Biopharma Corp to validate this buy or sell advice. Arbutus Biopharma buy-or-sell recommendation module provides average expert sentiment on the projected Arbutus Biopharma Corp target price to derive its highest and lowest estimates based on projected price volatility of 2.5611.
Lowest Forecast 4.63 | Highest Forecast 5.64 | Target Price 5.08 |
Arbutus |
It's important to approach Arbutus Biopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Arbutus Biopharma Target Price Consensus
Arbutus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Arbutus Biopharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Arbutus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Arbutus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Arbutus Biopharma Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationArbutus Biopharma Target Price Projection
Arbutus Biopharma's current and average target prices are 3.20 and 5.08, respectively. The current price of Arbutus Biopharma is the price at which Arbutus Biopharma Corp is currently trading. On the other hand, Arbutus Biopharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Arbutus Biopharma Market Quote on 20th of January 2025
Target Price
Analyst Consensus On Arbutus Biopharma Target Price
Arbutus Biopharma Analyst Ratings
Arbutus Biopharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Arbutus Biopharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Arbutus Biopharma's financials, market performance, and future outlook by experienced professionals. Arbutus Biopharma's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Arbutus Biopharma price targets
Arbutus Biopharma's stock target price is an estimate of its future price, usually made by analysts. Using Arbutus Biopharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Arbutus Biopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Arbutus Biopharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Arbutus Biopharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arbutus Biopharma is a key component of Arbutus Biopharma valuation and have some predictive power on the future returns of a Arbutus Biopharma.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arbutus Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 30 shares | |
 | Chemicals Invested over 30 shares | |
 | Automobiles and Trucks Invested over 300 shares | |
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.